Get the Stockscreener App
42.35
4.01%
-1.77
Hims Hers Health Inc stock is traded at $42.35, with a volume of 16.09M.
It is down -4.01% in the last 24 hours and down -29.73% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
See More
Previous Close:
$44.12
Open:
$44.2
24h Volume:
16.09M
Relative Volume:
0.44
Market Cap:
$9.22B
Revenue:
$1.78B
Net Income/Loss:
$164.40M
P/E Ratio:
61.38
EPS:
0.69
Net Cash Flow:
$236.51M
1W Performance:
-4.98%
1M Performance:
-29.73%
6M Performance:
+2.44%
1Y Performance:
+187.51%
1-Day Range:
$42.21
$44.49
1-Week Range:
$42.21
$46.29
52-Week Range:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
42.35 | 9.97B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
157.04 | 364.59B | 84.28B | 16.07B | 14.05B | 6.51 |
|
UL
Unilever Plc Adr
|
63.20 | 152.92B | 64.99B | 6.71B | 6.53B | 2.4495 |
|
CL
Colgate Palmolive Co
|
84.07 | 67.42B | 20.00B | 3.05B | 3.37B | 3.56 |
|
KMB
Kimberly Clark Corp
|
129.14 | 42.71B | 18.88B | 2.38B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
20.71 | 39.42B | 15.14B | 1.42B | 1.63B | 0.74 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Downgrade | Needham | Buy → Hold |
| Jun-04-25 | Reiterated | Needham | Buy |
| Apr-29-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Hers Health Inc.’s reversalGap Down & Stock Timing and Entry Methods - Newser
Hims & Hers: The Dominant Health Platform Of The Future (NYSE:HIMS) - Seeking Alpha
Hers Health Inc. reversing from oversold territoryM&A Rumor & Safe Entry Zone Identification - Newser
Hers Health Inc. stock trend forecast2025 Top Gainers & Daily Price Action Insights - Newser
Hers Health Inc.2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
Real time social sentiment graph for HIMSNew Guidance & Safe Entry Trade Reports - Newser
Hers Health Inc. stock entering bullish territoryTrade Exit Report & Growth Focused Entry Reports - Newser
Hims & Hers Health Insider Selling: Signal of Distrust or Strategic Rebalancing? - AInvest
Hers Health Inc. in the next 30 daysPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? - The Globe and Mail
Hims & Hers Health Stock Plunges 2.95% as Trading Volume Falls 32% to $890M and Drops to 67th in Activity - AInvest
Hims & Hers’ growth prospects clouded by Novo dispute and regulatory scrutiny - S&P Global
HIMS & HERS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Hims & Hers Scales Growth Through Subscriptions and Care Expansion - sharewise.com
Hims & Hers Health Is Looking to Cash In on This Novo Nordisk Blunder - The Motley Fool Canada
Hims & Hers Health Clears Key Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily
Hers Health Inc. stock performanceQuarterly Trade Review & Daily Growth Stock Investment Tips - Newser
Hims & Hers Stocks: Join the Pharma Boom? - StocksToTrade
Hims & Hers Health Stock (HIMS) Opinions on Telehealth Disruption and Recent Challenges - Quiver Quantitative
Hims & Hers Health Surges 5.15% on Intraday Rally—What’s Fueling the Momentum? - AInvest
Hims & Hers' Resilience Amid GLP-1 Market Shifts: Short-Term Volatility vs. Long-Term Personalized Care Positioning - AInvest
Hims & Hers Health, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
Hims & Hers: Navigating Short-Sellers and Regulatory Storms in the DTC Healthcare Sector - AInvest
Levi & Korsinsky Helps Shareholders SueWallSt After Hims & Hers Health, Inc. Stock Drops - Stockhouse
Hims & Hers Health: Navigating Regulatory Storms and Rebuilding a Growth Narrative - AInvest
Hims & Hers: A Case Study in Governance and Partnership Risks in the Digital Health Sector - AInvest
Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire - Benzinga
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers - Benzinga
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.
DEADLINE ALERT for HIMS, IRBT, and CNC: The Law Offices of - GlobeNewswire
Hims & Hers Health, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before August 25, 2025 to Discuss Your RightsHIMS - WV News
Is Regulatory Scrutiny and Novo Nordisk Partnership Loss Changing the Investment Case for Hims & Hers Health (HIMS)? - Yahoo Finance
Top 3 US Digital Health Stocks That are Leading the Healthcare Revolution - The Smart Investor
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Hims & Hers Health, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsHIMS - MarketScreener
Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class ActionContact Lieff Cabraser - ACCESS Newswire
Hers Health Inc. price bounce be sustainableMarket Growth Summary & AI Driven Stock Price Forecasts - Newser
Securities Class Action Risks in Digital Health Firms: A Deep Dive into Hims & Hers Health, Inc. - AInvest
Hims & Hers (HIMS) Stock Lawsuits: Investors Urged to Act - GlobeNewswire Inc.
HIMS DEADLINE TOMORROW: ROSEN, A LEADING NATIONAL FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action – HIMS - GlobeNewswire Inc.
Hers Health Inc. bounce back from current supportEntry Point & High Accuracy Trade Signal Alerts - Newser
HIMS Deadline: HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - PR Newswire
INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Levi & Korsinsky Notifies Hims & Hers Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – HIMS - GlobeNewswire
Hims & Hers: Navigating GLP-1 Regulation to Lead the Digital Obesity Revolution - AInvest
Hims & Hers: Personalized Care To Sustain Revenue Growth Despite GLP-1 Hiccup (NYSE:HIMS) - Seeking Alpha
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - PR Newswire
HIMS DEADLINE REMINDER: Important August 25, 2025 Deadline Reminder in Hims & Hers Health, Inc. Securities Class Action Lawsuit - PR Newswire
Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 - The Globe and Mail
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.36%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):